Decheng Capital Global Healthcare Fund (Master), LP 4
4 · ALPINE IMMUNE SCIENCES, INC. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
Transactions
- Purchase
Common Stock
2023-11-09$12.50/sh+375,000$4,687,500→ 1,735,544 total
Footnotes (1)
- [F1]The reportable securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Xiangmin Cui is the indirect managing member and ultimate beneficial owner of Healthcare GP. Each of Healthcare, Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Healthcare GP disclaims beneficial ownership of these securities, except to the extent of its pecuniary interest therein. Dr. Cui is a director of the Issuer and files separate Section 16 reports.